title: Who gets genomic testing for breast cancer recurrence risk?
abstract: OBJECTIVE
  Our study examined whether patient characteristics, beliefs and decision-making styles were associated with uptake of genomic testing for breast cancer recurrence risk.
  
  
  METHODS
  Participants were 132 early-stage breast cancer patients eligible for the Oncotype DX genomic test. We interviewed patients in 2009-2010 and obtained information from medical charts.
  
  
  RESULTS
  Half of the women eligible for genomic testing for breast cancer recurrence risk received it. The most common reason for not getting the test was that women's physicians did not offer it (80%). Test recipients were more likely to be unsure about receiving chemotherapy treatment compared to women who did not receive the test (p < 0.05). Women who received the test had less advanced disease pathologies, recalled a lower objective recurrence risk, perceived lower recurrence risk, and were slightly younger (all p < 0.05). Most women who described their decision-making style as active received the test (75%), whereas few women who described their style as passive received the test (12%) (p < 0.01).
  
  
  CONCLUSIONS
  In the university clinic we studied, genomic testing appeared to be more common among patients who may benefit most from the information provided by results, but confirmation in larger studies is needed.
authors.affiliation: Department of Health Behavior, UNC Gillings School of Global Public Health, Chapel Hill, N.C., USA.
authors.forename: J T
authors.initials: JT
authors.lastname: DeFrank
authors.forename: T
authors.initials: T
authors.lastname: Salz
authors.forename: K
authors.initials: K
authors.lastname: Reeder-Hayes
authors.forename: N T
authors.initials: NT
authors.lastname: Brewer
mesh_terms: D000367:Age Factors; D000368:Aged; D001943:Breast Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics* / Q000523:psychology*; D003657:Decision Making; D005260:Female; D005820:Genetic Testing / Q000706:statistics & numerical data*; D015894:Genome, Human / Q000235:genetics*; D023281:Genomics; D006801:Humans; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis / Q000235:genetics*; D009367:Neoplasm Staging; D012306:Risk
references.citation: J Clin Oncol. 2012 Jun 20;30(18):2218-26
references.pmid: 22585699
references.citation: Breast Cancer Res. 2006;8(3):R25
references.pmid: 16737553
references.citation: J Clin Oncol. 2006 Aug 10;24(23):3726-34
references.pmid: 16720680
references.citation: J Clin Oncol. 1994 Apr;12(4):843-50
references.pmid: 8151327
references.citation: BMC Fam Pract. 2006 Mar 24;7:21
references.pmid: 16563164
references.citation: J Clin Oncol. 2010 Apr 10;28(11):1829-34
references.pmid: 20212256
references.citation: Psychooncology. 2013 Sep;22(9):2110-6
references.pmid: 23447452
references.citation: J Behav Med. 2013 Dec;36(6):567-73
references.pmid: 22878783
references.citation: Cancer. 2012 Feb 1;118(3):788-96
references.pmid: 21720988
references.citation: J Clin Oncol. 2006 Mar 1;24(7):1090-8
references.pmid: 16505428
references.citation: J Clin Oncol. 2008 Feb 10;26(5):721-8
references.pmid: 18258979
references.citation: J Natl Cancer Inst. 2012 Jul 18;104(14):1068-79
references.pmid: 22767204
references.citation: Can J Nurs Res. 1997 Fall;29(3):21-43
references.pmid: 9505581
references.citation: N Engl J Med. 2004 Dec 30;351(27):2817-26
references.pmid: 15591335
references.citation: J Clin Oncol. 2007 Oct 10;25(29):4628-34
references.pmid: 17925559
references.citation: Am J Prev Med. 1999 Nov;17(4):285-94
references.pmid: 10606197
references.citation: Ann Intern Med. 1997 Dec 1;127(11):966-72
references.pmid: 9412301
references.citation: J Clin Oncol. 2001 Jun 1;19(11):2883-5
references.pmid: 11387361
references.citation: Ethn Dis. 2009 Autumn;19(4):473-8
references.pmid: 20073151
references.citation: Oncologist. 2007 Jun;12(6):631-5
references.pmid: 17602054
references.citation: Lancet Oncol. 2010 Jan;11(1):55-65
references.pmid: 20005174
references.citation: Cancer. 2010 Apr 15;116(8):1992-2000
references.pmid: 20213682